Global Pharmaceutical Industry Outlook: Growth Driven by Ageing Populations, Emerging Markets, and New Products
Looking ahead, global pharmaceutical production is expected to see solid growth, with forecasts predicting a 3% increase in 2024, 4% in 2025, and 3.6% in 2026. The Asia Pacific and Middle East regions are set to experience the highest annual growth rates.
In the medium to long term, manufacturers of specialty products, chronic condition treatments, and generic drugs will find growth opportunities due to ageing populations. The market for weight-loss medications is projected to reach around USD 80 billion by 2030.
United States: Strong Sales and Low Credit Risk in the Pharma Sector
In the U.S., pharmaceutical production is expected to grow by 2.9% in 2024 and 2.5% in 2025. After a sharp 17.3% rise in 2023, investments are forecasted to grow by 15.8% this year. An ageing population and rising demand for weight-loss drugs will continue to fuel market growth.
Branded pharmaceuticals enjoy strong margins, contributing to robust cash flow and healthy credit profiles. However, government efforts to lower drug prices could pose challenges for the industry.
Learn more here: https://atradius.ca/reports/industry-trends-pharmaceuticals-industry-trends-september-2024.html
